BrainEver Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 17

Employees

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $33M

  • Investors
  • 9

BrainEver General Information

Description

Operator of a medical research agency intended to develop drugs for the treatment of neurodegenerative disorders. The company's services specialize in the research and development of novel therapeutics using specific proprietary proteins to treat Parkinson's, amyotrophic lateral sclerosis, and Huntington's diseases, enabling healthcare practitioners to avail of drugs while providing the required treatment efficiently.

Contact Information

Website
www.brainever.fr
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 74 Rue du Faubourg
  • Saint-Antoine
  • 75012 Paris
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 74 Rue du Faubourg
  • Saint-Antoine
  • 75012 Paris
  • France

BrainEver Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BrainEver Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series B) 03-Jul-2025 $33M Completed Generating Revenue
9. Later Stage VC 01-Jan-2024 Completed Generating Revenue
8. Equity Crowdfunding Cancelled Generating Revenue
7. Secondary Transaction - Private Completed Generating Revenue
6. Later Stage VC 08-Jun-2022 Cancelled Generating Revenue
5. Grant 23-Mar-2022 Completed Generating Revenue
4. Early Stage VC 22-Sep-2019 Completed Generating Revenue
3. Early Stage VC (Series A2) 11-May-2017 Completed Generating Revenue
2. Early Stage VC (Series A) 11-May-2015 $1.1M $1.1M Completed Generating Revenue
1. Grant Completed Generating Revenue
To view BrainEver’s complete valuation and funding history, request access »

BrainEver Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A2 Shares
A2 Shares
A Shares 700,000 $0.011054 $1.58 $1.58 1x $1.58 18.18%
To view BrainEver’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

BrainEver Patents

  • 1

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 1

    Pending

  • Expiring in next 12 mo

BrainEver Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024207403-A1 Stabilized engrailed protein aqueous compositions Pending 13-Jan-2023

BrainEver Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BrainEver Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Critical Path Capital Corporation Minority
Relyens Impact Investing Minority
Entropia Capital Venture Capital Minority
European Innovation Council Venture Capital Minority
Indigo Capital Mezzanine Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

BrainEver FAQs

  • When was BrainEver founded?

    BrainEver was founded in 2015.

  • Where is BrainEver headquartered?

    BrainEver is headquartered in Paris, France.

  • What is the size of BrainEver?

    BrainEver has 17 total employees.

  • What industry is BrainEver in?

    BrainEver’s primary industry is Drug Discovery.

  • Is BrainEver a private or public company?

    BrainEver is a Private company.

  • What is BrainEver’s current revenue?

    The current revenue for BrainEver is .

  • How much funding has BrainEver raised over time?

    BrainEver has raised $54.9M.

  • Who are BrainEver’s investors?

    Critical Path Capital, Relyens, Entropia Capital, European Innovation Council, and Indigo Capital are 5 of 9 investors who have invested in BrainEver.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »